Smoking and ovulation inhibitor in inflammatory bowel diseases

Medizinische Klinik (Munich, Germany : 1983), 88 Suppl 1, 5-8, 1993

Source

Abstract

In a case-control study the effects of smoking and the use of oral contraceptives were examined in 83 patients with Crohn's disease and 37 patients with ulcerative colitis in comparison with members of the general population who served as controls. After controlling for oral contraceptives, smokers were found to have a significantly elevated relative risk of contracting Crohn's disease of 3.0 (1.3 to 6.8). Patients on oral contraceptives for more than three years had an elevated risk for Crohn's disease of 4.3 (1.3 to 14.4); this elevated risk was, however, found only in the non-smoking group. In the case of ulcerative colitis, the relative risk in smokers was significantly lower (0.21 [0.04 to 0.91]) than in non-smokers. The use of oral contraceptives does not represent a risk factor for ulcerative colitis. While smoking has been established as a risk factor in the development of inflammatory bowel disease, the role of oral contraceptives in the aetiology of this condition remains unclear.

Topics

oral contraceptives Crohn's disease risk case control study, smoking oral contraceptive use inflammatory bowel disease, oral contraceptive pills ulcerative colitis risk factor, Crohn's disease etiology hormonal contraception duration, Katschinski smoking contraceptive inflammatory bowel disease, oral contraceptive use greater than three years Crohn's disease risk, smoking protective factor ulcerative colitis epidemiology, contraceptive pill autoimmune gastrointestinal disease risk, hormonal contraception Crohn's disease non-smokers elevated risk, oral contraceptive side effects inflammatory bowel disease

Cite this article

Katschinski B (1993). Smoking and ovulation inhibitor in inflammatory bowel diseases. *Medizinische Klinik (Munich, Germany : 1983)*, *88 Suppl 1*, 5-8.

Related articles